tiprankstipranks
Jenscare Scientific Shows Promising Trial Results
Company Announcements

Jenscare Scientific Shows Promising Trial Results

Jenscare Scientific Co. Ltd. Class H (HK:9877) has released an update.

Don't Miss our Black Friday Offers:

Jenscare Scientific Co. Ltd. reports a 40.64% reduction in loss before tax for the first half of 2024 compared to the previous year, alongside promising developments in their cardiac device trials, including positive results for their LuX-Valve Plus and JensClip products. The company is poised to seek regulatory approval for its LuX-Valve Plus, reflecting advancements in their product pipeline and operations.

For further insights into HK:9877 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App